This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...
DexCom (NASDAQ:DXCM – Free Report) had its price objective trimmed by Royal Bank of Canada from $120.00 to $115.00 in a research report report published on Friday morning, Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback